An estimated 935 000 Americans suffer a myocardial infarction every year; because their
prognosis is determined by the size of the infarct, reducing infarct size is of paramount …

Purpose To investigate the prognostic value of circumferential left ventricular (LV) strain
measured by using cardiac MRI for prediction of major adverse cardiac events (MACE) …

Aldosteronism eventuates in a proinflammatory/fibrogenic vascular phenotype of the heart
and systemic organs. It remains uncertain whether peripheral blood mononuclear cells …

Chronic kidney disease (CKD) is increasingly prevalent in patients with heart failure (HF)
and HF is one of the leading causes of hospitalisation, morbidity and mortality in patients …

Aims Adverse left ventricular (LV) remodelling after ST-segment elevation myocardial
infarction (STEMI) is associated with poor outcome. Global and regional LV myocardial work …

Heart failure is a complex multifactorial disease resulting in a myriad of progressive changes
at the molecular, cellular, and physiological level. To better understand the mechanisms …

18F-galacto-RGD (18F-RGD) is a PET tracer binding to αvβ3 integrin receptors that are
upregulated after myocardial infarction (MI) as part of the healing process. We studied …

Nrf2 gene encodes a transcription factor regulating the expression of antioxidant and
detoxification genes. We test here whether Nrf2 plays a role for cardiac protection during …

Modern advanced imaging techniques have allowed increasingly more rigorous
assessment of the cardiac structure and function of several types of cardiomyopathies. In …

We synthesized a cationic microbubble (CMB) with the aim of enhancing its DNA-carrying
capacity to improve targeted gene transfection of the ischemic heart for cardiac …